Abstract
Nowadays, biotechnological processes play a pivotal role in target protein production. In this context, Chinese Hamster Ovary (CHO) cells are one of the most prominent cell lines for the expression of recombinant proteins and revealed as a safe host for nearly 40 years. Nevertheless, the major bottleneck of common in vivo protein expression platforms becomes obvious when looking at the production of so called “difficult-to-express” proteins. This class of proteins comprises in particular several ion channels and multipass membrane proteins as well as cytotoxic proteins. To enhance the production of “difficult-to-express” proteins, alternative technologies were developed, mainly based on translationally active cell lysates. These so called “cell-free” protein synthesis systems enable an efficient production of different classes of proteins. Eukaryotic cell-free systems harboring endogenous microsomal structures for the synthesis of functional membrane proteins and posttranslationally modified proteins are of particular interest for future applications. Therefore, we present current developments in cell-free protein synthesis based on translationally active CHO cell extracts, underlining the high potential of this platform. We present novel results highlighting the optimization of protein yields, the synthesis of various “difficult-to-express” proteins and the cotranslational incorporation of non-standard amino acids, which was exemplarily demonstrated by residue specific labeling of the glycoprotein Erythropoietin and the multimeric membrane protein KCSA.
Highlights
Nowadays, production of recombinant proteins plays a pivotal role in the pharmaceutical industry
Our newly developed cell-free system based on Chinese Hamster Ovary (CHO) cell lysates requires a T7- promoter- and terminator sequence introduced upstream of the gene sequence to realize transcription of RNA conducted by T7 RNA polymerase
The first part of this study included cell-free synthesis based on different vector backbones such as pIX3.0-cricket paralysis virus (CRPV)(GCT)-Luc, pcDNA3.1CRPV(GCT)-Luc, pGem-encephalomyocarditis virus (EMCV)-Luc and pT7CFE1-EMCV-Luc (Table 1). pIX3.0 and pT7CFE1 based vectors are currently used for cell-free synthesis in commercially available cell
Summary
We aimed to analyze the flexibility of template acceptance in the CHO cell-free system
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.